Andreyev, H. J., Benton, B., Lalji, A., et al. (2013). Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial. Lancet, 382, 2084–2092.CrossRef

Ansink, A., van der Velden, J. and Collingwood, M. (2000). Surgical intervention for early squamous cell carcinoma of the vulva. Cochrane Database Syst. Rev., 4.Google Scholar

Beller, U, Quinn, M. A., Benedet, J. L., et al. (2006). Carcinoma of the vulva. FIGO 26th annual report on the results of treatment in gynecological cancer. Int. J. Gynaecol. Obstet., 95(Suppl. 1), S7–27.Google ScholarPubMed

Beriwal, S., Coon, D., Heron, D. E., et al. (2008). Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol. Oncol., 109, 291–295.CrossRefGoogle ScholarPubMed

Board of the Faculty of Clinical Oncology, Royal College of Radiologists. (2006). Radiotherapy Dose-Fractionation. London: Royal College of Radiologists.

Cunningham, M. J., Goyer, R. P., Gibbons, S. K., et al. (1997). Primary radiation, cisplatin and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol. Oncol., 66, 258–261.CrossRefGoogle ScholarPubMed

de Sanjosé, S., Alemany, L., Ordi, J., et al. (2013). Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur. J. Cancer, 49, 3450–3461.CrossRefGoogle ScholarPubMed

Faul, C. M., Mirmow, D., Huang, Q., et al. (1997). Adjuvant radiation for vulvar carcinoma: improved local control. Int. J. Radiat. Oncol. Biol. Phys., 38, 381–389.CrossRefGoogle ScholarPubMed

Gaarenstroom, K. N., Kenter, G. G., Trimbos, J. B., et al. (2003). Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int. J.Gynecol. Cancer, 13, 522–527.CrossRefGoogle ScholarPubMed

Gadducci, A., Cionini, L., Romanini, A., et al. (2006). Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit. Rev. Oncol. Hematol., 60, 227–241.CrossRefGoogle ScholarPubMed

Hacker, N. F., Leuchter, R. S., Berek, J. S., et al. (1981). Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet. Gynecol., 58, 574–579.Google ScholarPubMed

Hacker, N.F., Eifel, P.J. and Van der Velden, J. (2012). FIGO cancer report 2012, cancer of the vulva. Int. J. Gynecol. Cancer, 119(Suppl. 2), S90–S96.Google Scholar

Hassanzade, M., Attaran, M., Treglia, G., et al. (2013). Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol. Oncol., 130, 237–245.CrossRefGoogle ScholarPubMed

Heaps, J. M., Fu, Y. S., Montz, F. J., et al.(1990). Surgical–pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol. Oncol., 38, 309–314.CrossRefGoogle ScholarPubMed

Homesley, H. D., Bundy, B. N., Sedlis, A., et al. (1986). Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet. Gynecol., 68, 733–740.Google ScholarPubMed

Horowitz, N. S., Olawaiye, A. B., Borger, D.R., et al. (2012). Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol. Oncol., 127, 141–146.CrossRefGoogle ScholarPubMed

Iacoponi, S., Zapardiel, I., Diestro, M. D., et al. (2013). Prognostic factors associated with local recurrence in squamous cell carcinoma of the vulva. J. Gynecol. Oncol., 24, 242–248.CrossRefGoogle ScholarPubMed

Koh, W. J., Wallace, H. J. 3rd, Greer, B. E., et al. (1993). Combined radiotherapy and chemotherapy in the management of locally–regionally advanced vulvar cancer. Int. J. Radiat. Oncol. Biol. Phys., 26, 809–816.CrossRefGoogle Scholar

Land, R., Herod, J., Moskovic, E., et al. (2006). Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva. Int. J. Gynecol. Cancer, 16, 312–317.CrossRefGoogle ScholarPubMed

Levenback, C. F., Ali, S. and Coleman, R. L. (2012). Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J. Clin. Oncol., 30, 3786–3791.CrossRefGoogle ScholarPubMed

Maggino, T., Landoni, F., Sartori, E., et al. (2000). Patterns of recurrence in patients with squamous cell carcinoma of the vulva. Cancer, 89, 116–122.3.0.CO;2-4>CrossRefGoogle ScholarPubMed

Moore, D. H., Thomas, G. M., Montana, G. S., et al. (1998). Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int. Radiat. Oncol. Biol. Phys., 42, 79–85.CrossRefGoogle ScholarPubMed

NICE. (2015). Suspected cancer: recognition and referral. NICE guideline.London: National Institute for Health and Care Excellence.

Pecorelli, S. (2009). Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynecol. Obstet., 105(2), 103–104.Google ScholarPubMed

RCOG/BGCS. (2014). Guidelines for the Diagnosis and Management of Vulval Carcinoma.London: Royal College Obstetricians and Gynaecologists.

Robison, K., Fiascone, S. and Moore, R. (2014). Vulvar cancer and sentinel lymph nodes: a new standard of care?Expert Rev. Anticancer Ther. 14, 975–977.CrossRefGoogle ScholarPubMed

Russell, A. H., Mesic, J. B., Scudder, S. A., et al. (1992). Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol. Oncol., 47, 14–20.CrossRefGoogle ScholarPubMed

Shylasree, T. S., Bryant, A. and Howells, R. E. J. (2011). Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst. Rev., Issue 4, CD003752.Google ScholarPubMed

Thomas, G., Dembo, A., DePetrillo, A., et al. (1989). Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol. Oncol., 34, 263–267.CrossRefGoogle ScholarPubMed

UICC. (2009). TNM Classification of Malignant Tumours, ed. Sobin, L.H., Gospodarowicz, M. and Wittekind, Ch., 7th edn. Chichester: Wiley-Blackwell.

Van der Zee, A. G., Oonk, M. H., De Hullu, J. A., et al. (2008). Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J. Clin. Oncol., 26, 884–889.CrossRefGoogle ScholarPubMed

van Doorn, H. C., Ansink, A., Verhaar-Langereis, M., et al. (2006). Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst. Rev., Jul 19;(3):CD003752.Google ScholarPubMed

Wagenaar, H. C., Colombo, N., Vergote, I., et al. (2001). Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol. Oncol., 81, 348–354.CrossRefGoogle ScholarPubMed

Wahlen, S. A., Slater, J. D., Wagner, R. J., et al. (1995). Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer, 75, 2289–2294.3.0.CO;2-4>CrossRefGoogle ScholarPubMed

WHO. (2003). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs, ed. Tavassoli, F.A. and Devilee, P.. Lyon: IARC Press, Chapter 7.

Witteveen, P. O., Van der Velden, J. and Vergote, I. (2009). Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer – Gynaecological Cancer Group). Ann. Oncol., 20, 1511–1516.CrossRefGoogle Scholar

Zanvettor, P. H., Falcão Filho, D. F., Soares, F. A., et al. (2014). Study of biomolecular and clinical prognostic factors in patients with cancer of the vulva undergoing surgical treatment. Int. J. Gynecol. Cancer, 24, 766–772.CrossRefGoogle ScholarPubMed